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Abstract
Staphylococcus aureus, a major human pathogen, exacerbates allergic disorders, including atopic dermatitis, nasal polyps
and asthma, which are characterized by tissue eosinophilia. Eosinophils, via their destructive granule contents, can cause
significant tissue damage, resulting in inflammation and further recruitment of inflammatory cells. We hypothesised that the
relationship between S. aureus and eosinophils may contribute to disease pathology. We found that supernatants from S.
aureus (SH1000 strain) cultures cause rapid and profound eosinophil necrosis, resulting in dramatic cell loss within 2 hours.
This is in marked contrast to neutrophil granulocytes where no significant cell death was observed (at equivalent dilutions).
Supernatants prepared from a strain deficient in the accessory gene regulator (agr) that produces reduced levels of many
important virulence factors, including the abundantly produced a-hemolysin (Hla), failed to induce eosinophil death. The
role of Hla in mediating eosinophil death was investigated using both an Hla deficient SH1000-modified strain, which did
not induce eosinophil death, and purified Hla, which induced concentration-dependent eosinophil death via both apoptosis
and necrosis. We conclude that S. aureus Hla induces aberrant eosinophil cell death in vitro and that this may increase tissue
injury in allergic disease.
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Introduction
Eosinophils and their products are major components of allergic
inflammation in tissues, in particular in atopic dermatitis, rhinitis
and asthma, where their abundance in the tissues and circulation
correlates with disease severity [1,2,3,4]. As granule-containing
leukocytes, eosinophils can damage tissue cells via the release of
toxic mediators including eosinophil cationic protein (ECP), major
basic protein, eosinophil-derived neurotoxin and eosinophil
peroxidase (EPO). These mediators can directly damage the
airway epithelium, induce mast cell histamine release and increase
airway responsiveness via contraction of smooth muscle [5,6].
Mediator release can occur following degranulation, as part of the
innate immune response, but also via cell rupture. In the absence
of an activation stimulus eosinophils undergo constitutive
apoptosis, in the same way as the shorter-lived neutrophil
granulocytes, and this is followed by clearance via tissue
macrophages [7]. This anti-inflammatory process limits the
destruction mediated by intracellular proteases and promotes the
resolution of inflammation. The process of immune cell apoptosis
can be dysregulated by pathogens, which are well known to disrupt
the death pathways of both monocyte-macrophages and neutro-
phils as a survival strategy [8,9,10]. Similarly eosinophils, as key
anti-parasitic cells, are targeted by parasites, which induce
premature eosinophil apoptosis as a mechanism of immune
evasion [11,12,13]. Although eosinophils are not usually consid-
ered to play a significant role in immune defences against bacteria,
some studies have shown they possess anti-bacterial capabilities,
mediated by their granule contents [14,15] and the more recently
discovered release of mitochondrial DNA [16].
The important human pathogen, S. aureus, exacerbates the
pathology of allergic diseases that are typically characterised by
tissue eosinophilia, in particular atopic dermatitis [17,18], nasal
polyps [19,20] and asthma [21]. S. aureus produces a number of
virulence factors pertinent to its survival in the host, notably
cytolysins which include the hemolysins ( a, b, c and d) and
Panton-Valentine leukotoxin (PVL). It is unclear, however, how
the relationship between S. aureus and eosinophils may contribute
to disease and the effects of S. aureus upon eosinophil viability had
not been examined. In these studies we show S. aureus mediates
rapid eosinophil cell death and that the cytolysin Hla is a major
contributory factor in eosinophil death.
Materials and Methods
Bacterial information and culture
The Staphylococcus aureus wild type (WT) SH1000 strain and its
corresponding agr derivative were used [22]. The Hla deficient
SH1000 hla strain was created from DU1090 [23] via transduction
[24] using phage w11 and selection for erythromycin (5 mg/ml)
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and lincomycin (25 mg/ml) resistance. S. aureus was grown on LB
plates (supplemented with tetracycline 5 mg/ml for agr and
erythromycin 5 mg/ml and lincomycin 25 mg/ml for hla) from
which single colonies were picked and inoculated into 5 ml LB
broth for an overnight shaking culture (18 hr). For complemen-
tation of SH1000 hla to yield the strain hla+hla, the hla gene plus an
812-bp sequence upstream of the open reading frame was
amplified using primers F-ApaI and R-BamHI (see table 1). The
fragment was cloned as an ApaI/BamHI fragment into similarly
cut pGL485 [25], and the resulting construct (pJC001) and
pGL485 (control) were transformed into S. aureus RN4220 by
selection on chloramphenicol [26]. Phage transduction [24]) using
w11 was used to transfer pJC001 and pGL485 into SH1000 and
SH1000 hla. Successful complementation was confirmed by colony
PCR, using plasmid specific primers covering the insert region
(ALB23 and ALB24, see table 1). Bacterial yield was determined to
be comparable for all cultures by serial dilution and plating onto
LB plates. Culture supernatants from liquid cultures were
produced by removal of bacteria by repeated microcentrifugation
at 6000 RPM and filtration (0.45 mm). Hla (60% protein content
by Lowry activity $10,000 units/mg protein) was obtained from
Sigma-Aldrich (Dorset, UK).
Preparation and culture of eosinophils
Granulocytes were isolated from fresh whole blood from healthy
human volunteers by dextran sedimentation and plasma-percoll
Table 1. Oligonucleotides used for complementation.
Oligonucleotide Sequence 59-39
F-ApaI ATAATAGGGCCCACTCTGTCATTTTTAATCCCCTTTC
R-BamHI ATAATAGGATCCAAACCATTTGTTAACCTCCTTGAAC
ALB23 TGTGAGGGGATAACAATTCCCC
ALB24 TTCCTTTCGGGCTTTGTTAGCAG
doi:10.1371/journal.pone.0031506.t001
Figure 1. Identifying eosinophils in mixed granulocyte cultures. Cells were dual stained with CD66c-PE and CCR3-FITC and were analysed by
flow cytometry. A, CD66c-PE (FL2-H axis) and CCR3-FITC (FL1-H axis) dual stained cells confirm a population of CCR3-positive/CD66c-low events (top
left quadrant). B, Corresponding isotype controls. C, Identification of CCR3-positive events and the respective FSC/SSC profile of gated CCR3 positive
events (D). E, Identification of CC66c-low events and the respective FSC/SSC profile of gated CC66c-low events (F).
doi:10.1371/journal.pone.0031506.g001
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centrifugation [27]. All subjects gave informed consent and ethical
approval was given by the Sheffield Research Ethics Committee.
Purity was assessed by counting .500 cells on duplicate slides and
granulocytes were typically 5–15% eosinophils. In selected
experiments, eosinophils were further purified from granulocyte
populations by negative magnetic selection using a human
eosinophil enrichment kit and RoboSep technology (StemCell
Technologies, Vancouver, BC, Canada) yielding populations of
.95% eosinophils. Cells were cultured at a density of 2.56106/ml
in RPMI 1640 supplemented with 10% FCS and 1% penicillin/
streptomycin, in 96 well polypropylene plates (Becton Dickinson)
at 37uC/5% CO2.
Assessment of cell death
Light microscopy: Eosinophils display characteristic morphological
nuclear changes during apoptosis that can be visualised by light
microscopy [7]. Cytocentrifuge slides (cytospins, Shandon) were
prepared from cell cultures at the time points indicated, fixed and
stained with modifiedWright-Giemsa stain (Diff-Quik). Apoptosis was
assessed by counting .100 eosinophils per slide of duplicate pairs.
Figure 2. S. aureus supernatant rapidly induces eosinophil cell death. Mixed granulocytes were cultured with media (black bars) or S. aureus
supernatant (1023, open bars) for 15, 30, 45, 60 or 120 mins. Cells were stained with CD66c-PE and ToPro-3 and analysed by flow cytometry along
with Countbright beads. Eosinophils were gated out as CD66c-PE low events (A–C). (A) representative flow cytometry histograms showing ToPro-3
staining of eosinophils and neutrophils following treatment with S. aureus supernatant. Charts show changes in percentage eosinophil ToPro-3
positivity (B), and total eosinophil number (C). (D) Shows percentage ToPro-3 positive neutrophils (CD66c high events). Data are shown as mean
6SEM from 3 independent experiments and statistically significant differences calculated by ANOVA with Bonferoni’s post-test (*p$0.05, **p$0.01,
*** p$0.001).
doi:10.1371/journal.pone.0031506.g002
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Flow cytometry: Eosinophils were studied in mixed granulocyte
populations using antibodies to CD66c-PE (BD Biosciences) as a
positive marker for neutrophils which highly express CD66c
compared to eosinophils which dimly stain for CD66c. This was
verified by showing both that the CD66c-PE low events were also
CCR3-FITC positive (when used), and that they fit a FSC-SSC
profile consistent with that of eosinophils (fig. 1) [28]. Cells were
washed in ice-cold PBS and stained with CD66c-PE and the vital
dye ToProH-3 iodide (Molecular Probes, Eugene, OR) as a
measure of necrosis/cell lysis. Expression of phosphatidylserine
(PS) on the outer leaflet of the plasma membrane is a well-
established early marker of apoptosis [29]. Apoptotic eosinophils
have been shown to bind to the phosphatidylserine probe Annexin
V-FITC [30] and in selected experiments cells were also stained
with Annexin V-FITC (BD Biosciences) to determine rates of
apoptosis. Matched isotype control antibodies (mouse IgG1k-PE
and mouse IgG2a-FITC, BD Biosciences) were also used to
confirm levels of non-specific binding. Countbright beads
Figure 3. S. aureus supernatant induces eosinophil cell death at high dilutions.Mixed granulocytes were cultured with media (black bars) or
a range of dilutions of S. aureus supernatant (open bars) for 2 hours. A, representative flow cytometry histograms showing loss of CD66c-low
population and increases in ToPro-3 positivity of that population with supernatant treatment. Charts show changes in percentage eosinophil ToPro-3
positivity (B), and total eosinophil number (C). Data are shown as mean 6SEM from 7 independent experiments and statistically significant
differences calculated by ANOVA with Dunnett’s post-test (*p$0.05).
doi:10.1371/journal.pone.0031506.g003
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(Molecular Probes) were also acquired with each sample to
measure total cell number. Data from 30,000 events were
recorded from each sample by flow cytometry (FACScalibur,
Becton Dickinson, CA) and analysed using FlowJo software (Tree
Star Inc, Ashland, OR). Experiments where numbers of
eosinophils fell below 500 events were not included.
Using this staining protocol it was possible to measure total
eosinophil cell number and to assess the percentage of cells that
were either apoptotic (Annexin V+ve/ToPro3-ve, dual positive) or
necrotic (ToPro3+ve).
Statistics
Statistical analysis was performed using PRISM v5 (GraphPad
Software, San Diego, CA) and the tests indicated in the figure
legend.
Results
S. aureus induces eosinophil cell death via a bacterial-
associated factor
The study of eosinophils in mixed granulocytes allowed the
simultaneous study of two key inflammatory immune cells and
their responses to an important human pathogen. Individual cell
populations were identified within mixed granulocytes on the basis
of their CD66c bright staining (neutrophils) or low staining
(eosinophils, fig. 1). A fluorescent CCR3 antibody was not an
appropriate method of staining eosinophils in these experiments
since CCR3 signals were lost upon treatment with bacterial
supernatant and therefore gating eosinophils as CCR3 positive
events by flow was unreliable (data not shown). These studies
revealed a significant difference between the granulocytes with
respect to their sensitivity to S. aureus. Cells were treated with cell-
free bacterial supernatant prepared from overnight growth of S.
aureus in LB broth. Initial experiments to establish dilution ranges
and time points revealed a potent and rapid pro-death effect of the
supernatant on eosinophils and this was characterized using flow
cytometry. Mixed granulocytes were cultured with media alone or
with S. aureus supernatant (1 in 1,000 dilution) for time points up to
2 hours followed by staining with CD66c-PE and ToPro-3 and
measurement of absolute cell loss using fluorescent beads. S. aureus
supernatant induced significant eosinophil necrosis by 159, with an
increase in ToPro-3 positive events (fig. 2B) within the CD66c-low
population. This was followed by significant loss of eosinophils at
the later timepoint of 60 mins (3.5610465.56103 eosinophils in
control compared to 1.5610462.86103 for supernatant treated
cells, fig. 2C), suggesting cell necrosis precedes loss of cells from the
population. The rapidity of eosinophils becoming ToPro3+ve
suggested they were undergoing primary necrosis and this was
confirmed by there being no detection of an Annexin V+ve/
ToPro3-ve population preceding the appearance of necrotic cells
Figure 4. An equivalent degree of cell death is observed when eosinophils are treated in purified populations. Eosinophils were
further purified from mixed leukocyte populations by negative magnetic selection yielding populations of 9960.2% purity. Cells were incubated with
media or S. aureus supernatant for 30 mins (black bars) or 120 mins (open bars) and ToPro-3 positivity and cell loss (Countbright beads) was
measured by flow cytometry. A, representative light microscopy images of eosinophils undergoing cell death following treatment with media
(control) or supernatant diluted at 1:103. Cells were sampled at 30 and 120 mins. Charts show changes in ToPro-3 positivity (B) and total cell number
(C) from 3 independent experiments. Data are expressed at mean 6 SEM and statistically significant differences between treatment and relevant
control were calculated by ANOVA with Bonferoni post-test (*p$0.05, **p$0.01, *** p$0.001).
doi:10.1371/journal.pone.0031506.g004
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(data not shown). In contrast, neutrophils were relatively
unaffected by the bacterial supernatant, only showing a small yet
significant increase in ToPro-3 positivity at 120 mins (fig. 2D).
There was no detectable neutrophil cell loss at any timepoint (data
not shown).
Further experiments explored the lytic potency of the bacterial
supernatants. Even at dilutions as high as 1 in 10,000, S. aureus
supernatant significantly increased the percentage of ToPro-3
positive events (fig. 3B), which correlated with a significant
reduction in the total number of eosinophils (fig. 3C). Eosinophils
further purified from granulocyte populations by negative
magnetic separation were also susceptible to an equivalent degree
of cell death by S. aureus supernatant (fig. 4).
To determine whether the death-inducing factor(s) was of a
proteinaceous nature, supernatant was heat-treated (100uC,
10 mins) or digested for 2 hours with proteinase K and the effect
on eosinophil cell death examined (fig. 5). Although proteinase K
treatment significantly abrogated the pro-death effect, heat-treated
supernatant retained its ability to induce eosinophil cell death,
suggesting the factor(s) is a heat-stable protein.
Production of the pro-necrotic factor(s) is controlled by
the agr locus
Since cellular effects similar to the ones we have observed are
typically due to secreted bacterial toxins, we prepared supernatants
from a S. aureus mutant deleted for the agr locus which controls the
expression of key virulence factors [31]. These mutants lack
expression of the a-, b-, d-, and c-hemolysins, leukocidins,
enterotoxins and TSST-1 [31]. Bacterial cultures of SH1000 and
its isogenic agr derivative were grown simultaneously and CFU counts
shown to be comparable. Supernatant prepared from the agr deficient
strain did not induce eosinophil ToPro-3 positivity (fig. 6A, B) or cell
loss (fig. 6C, D) in contrast to the WT supernatant, suggesting
production of the pro-death factor(s) requires the agr locus.
An Hla deficient supernatant fails to induce eosinophil
cell death
We hypothesised that Hla played a key role in this rapid necrosis
since this toxin is a key cytolytic factor, is controlled by the agr locus
and Hla-positive strains are commonly isolated from patients with
eosinophillic diseases such as atopic dermatitis [32,33]. To test this,
supernatant was prepared from an Hla deficient strain (hla) and
eosinophil cell death assessed after 30 and 120 mins. Figure 6 shows
that, despite profound effects of the WT supernatant, the hla
supernatant did not cause ToPro-3 positivity (fig. 7A, B) or cell loss
(fig. 7C, D) compared to the WT counterpart at either time point. It
was observed that more concentrated preparations (1 in 100
dilution) of hla supernatant induced moderate eosinophil cell death
in these assays (3.762.3% ToPro-3 positivity in control vs
12.665.9% in hla supernatant diluted 1 in 100 after 30 mins) that
was comparable to the profound cell death seen with substantially
more diluted WT supernatants (data not shown). In genetic
complementation experiments, the hla mutant was genetically
reconstituted with a plasmid expressing Hla to further demonstrate
the eosinophil killing abilities of Hla in bacterial supernatant.
Figure 7E, F show treatment with hla+hla supernatant results in a
significant increase in ToPro-3 positivity and significant decrease in
eosinophil number respectively, therefore restoring the death-
inducing capacity of the Hla deficient supernatant. To provide
further confirmation that Hla was a potent eosinophil lysogen,
granulocytes were incubated with a concentration range of purified
Hla for 1 (fig. 8A) and 3 hours (fig. 8B) and eosinophil cell death
assessed by flow cytometry. Eosinophils, gated as CD66c-low
events, stained positively with Annexin-V and ToPro-3 at
concentrations of Hla $1 mg/ml (fig. 8A, B: open bars and shaded
bars respectively). This staining was accompanied by a drop in total
cell number indicating these apoptotic/secondary necrotic cells
were undergoing lysis (fig. 8A, B: closed bars). Since dual positivity
of Annexin-V and ToPro-3 can indicate that cells have either
undergone apoptosis or necrosis (when Annexin-V stains the PS on
the inner membrane), we examined Hla treated eosinophils by light
microscopy for morphological changes associated with apoptosis
after 5 (fig. 8C) and 24 hours (fig. 8D). Eosinophils displayed distinct
morphological changes of apoptosis, including nuclear condensa-
tion and cell shrinkage and this reached significance at 100 ng/ml
Hla at 5 hours (fig. 8C) and 1 ng/ml at 24 hours (fig. 8D). The bell-
shaped nature of the concentration response curve further supports
the hypothesis that cells are lost at higher concentrations ($1 mg/
ml) of Hla. In contrast, neutrophil apoptosis as assessed by Annexin-
V positivity (fig. 7A) and morphology (fig. 8E), was modestly
Figure 5. Pro-death effect of supernatant is lost with protein-
ase K treatment but is not affected by boiling. Mixed
granulocytes were cultured with media (control, black bars), or S.
aureus supernatant treated in the following way: untreated (native,
open bars), boiled (horizontal lines) or proteinase K digestion (diagonal
lines) for 2 hours. Cells were stained with CD66c-PE and ToPro-3 and
analysed by flow cytometry along with Countbright beads. Eosinophils
were gated out as CD66c-low events. Charts show changes in
percentage eosinophil ToPro-3 positivity (A), and total eosinophil
number (B). Data are shown as mean 6SEM from 3 independent
experiments and statistically significant differences calculated by
ANOVA with Bonferoni’s post-test (*p$0.05).
doi:10.1371/journal.pone.0031506.g005
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increased and not statistically significant at either timepoint. The
pro-death effect of Hla was confirmed in purified populations of
eosinophils (fig. 8F, G, H), where statistical significance was
achieved at 1 mg/ml Hla at 5 hours and 10 ng/ml at 24 hours,
suggesting that although still profoundly cytotoxic, Hla was less
potent when treating pure populations of eosinophils.
Discussion
Bacterial colonization with S. aureus is a prominent feature of
conditions such as atopic dermatitis [34,35], with a correlation
between numbers of bacteria present on the skin and disease
severity. Furthermore, anti-microbial treatments lead to improve-
ment in skin lesions, suggesting a causal relationship [36,37]. S.
aureus has also been implicated in the development of nasal polyps
[19,20] and a role for staphylococcal enterotoxins has been
described in asthma [38].
In these studies we describe the ability of S. aureus to profoundly
reduce eosinophil viability via an Hla dependent mechanism. Pro-
death activity was observed in heat-treated supernatant, indicating
it was attributable to a heat-stable factor(s) and in support of this,
Hla has been shown to have a high tolerance to heat [39]. This
together with the loss of activity after proteinase K treatment
confirmed that the pro-death factor was a heat-resistant protein.
Hla is a clinically important pore forming toxin which is
produced by the vast majority of clinical strains of S. aureus [40]. It
has been implicated in many diseases, in particular pneumonia,
and septic arthritis [41,42,43], as well as brain abscesses [44].
Secreted as a 33 kDa monomer, Hla binds to the target cell
plasma membrane and oligomerises into hexamers or heptamers
before inserting into the lipid bilayers to form pores [45]. Cell
toxicity is rapidly achieved due to the destruction of the plasma
membrane, leak of cellular ions or via delivery of toxic compounds
through the pores. The concentration of Hla is critical for
governing the mode of death: at low doses (Hla,100 ng/ml) cell
death is typically via caspase-mediated apoptosis whereas at higher
concentrations cell death occurs by necrotic mechanisms
[46,47,48,49,50,51]. The effects of Hla are also time dependent;
in epithelial cells a transient phase of apoptosis is followed by
cellular necrosis [52]. On the whole, Hla is thought to
predominantly induce necrosis, particularly when present with
other bacterial factors. In our studies we have shown that in
isolation, Hla induces eosinophil apoptosis (determined by
morphological changes and PS exposure measured by Annexin-
V positivity) at low concentrations (,100 ng/ml) and early time
points (,5 hours), but induces necrosis and subsequent cell loss at
concentrations in excess of 1 mg/ml. It is worth noting that
standard Hla preparations contain some impurities and we cannot
exclude the possibility that other agents in the Hla may have
contributed to the cytotoxicity observed. When present in bacterial
supernatant, Hla appears to contribute to a principally necrotic
death, characterised by rapid ToPro-3 positivity occurring within
15 mins and ensuing cell loss by 2 hours. This is likely to be the
result of high concentrations of Hla that have accumulated during
Figure 6. ToPro-3 positivity and cell loss is not seen in supernatants prepared from S. aureus agr. Mixed granulocytes were cultured with
media (lined bars) or WT (closed bars) or agr (open bars) S. aureus supernatant at 1:104 and 1:103 for 30 (A, C) or 120 (B, D) mins. Cells were stained
with CD66c-PE and ToPro-3 and were analysed alongside Countbright beads by flow cytometry. Eosinophils were gated out as CD66c-low events.
Charts show changes in percentage eosinophil ToPro-3 positivity (A, B) and total eosinophil number (C, D). Data are shown as mean 6SEM from 4
independent experiments and statistically significant differences calculated by ANOVA with Bonferoni’s post-test (*p$0.05, **p$0.01).
doi:10.1371/journal.pone.0031506.g006
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Figure 7. Supernatant prepared from a Hla mutant (hla) does not induce eosinophil cell death. Mixed granulocytes were cultured with
media (lined bars) or a range of dilutions of WT (closed bars) or hla (open bars) S. aureus supernatant for 30 (A, C) or 120 (B, D) mins. Cells were
stained with CD66c-PE and ToPro-3 and were analysed alongside Countbright beads by flow cytometry. Eosinophils were gated out as CD66c-low
events. Charts show changes in percentage eosinophil ToPro-3 positivity (A, B) and total eosinophil number (C, D). In separate experiments mixed
granulocytes were also incubated with supernatants from plasmid HLA complemented hla (hla+hla vertical lined bars) for 120 mins. Cells were stained
with CD66c-PE and ToPro-3 and were analysed as described above. Charts show changes in percentage eosinophil ToPro-3 positivity (E) and total
eosinophil number (F). Data are shown as mean6SEM from 3 independent experiments and statistically significant differences calculated by ANOVA
with Bonferoni’s post-test (*p$0.05, **p#0.01, ***p#0.001).
doi:10.1371/journal.pone.0031506.g007
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the overnight growth period. It could also be attributable to other
cellular disrupting factors that may act either to sensitise the cell to
pore formation by damaging the plasma membrane or to mediate
cellular damage by a different mechanism. This is supported by
the ability of the Hla deficient mutant to cause moderate levels of
eosinophil cell death with more concentrated supernatant
preparations, suggesting a minor role for other factors and a
dominant role for Hla. It is worth noting that other factors
produced by other S. aureus strains with alternative toxin profiles
may also have a role in eosinophil-induced cell toxicity however,
based on the findings in this study, we show that the critical factor
in S. aureus-induced eosinophil cell death is Hla.
Interestingly, we showed neither S. aureus supernatants nor
purified Hla induced death of neutrophils granulocytes. In support
of this, published data confirm neutrophils are remarkably resistant
to cell death mediated by Hla [53], with Hla unable to form a pore
in neutrophil cell membranes. The different susceptibility of these
two closely-related cell types suggests neutrophil resistance is likely
to represent a host defence mechanism evolved to provide effective
defence against bacteria producing lytic toxins such as Hla. S. aureus
supernatant was able to induce modest but statistically significant
levels of neutrophil ToPro-3 positivity at late time points. This could
be due to the fact that neutrophils are relatively, rather than
absolutely resistant to Hla, or attributable to the effects of high levels
of eosinophil lysis within the mixed granulocyte populations
(causing damage to the neutrophil plasma membrane and therefore
uptake of the vital dye) rather than being a direct effect of Hla. It is
yet to be elucidated whether the eosinophil cell death is a host- or
pathogen- mediated process. The rapid and pro-necrotic death
suggests a pathogen-mediated phenomenon, both since death by
apoptosis would be a preferable mechanism for the host and since in
vivo disease models have shown Hla mutants have reduced virulence
[43,54,55,56,57]. Recent animal models clearly demonstrate that
Hla contributes to disease pathogenesis in S. aureus skin infections,
where Hla deficient strains result in smaller skin lesions compared to
wild type strains and that vaccination against Hla reduces disease
severity [56,57]. In addition, the dermonecrosis visible following
infection by wild type strains is not seen in Hla negative mutants,
which supports a pro-necrotic role for Hla in vivo [56]. Nonetheless,
host benefits are also possible: eosinophil cationic protein (ECP) has
been shown to have bactericidal effects against S. aureus [14] so that
eosinophil lysis at the site of infection could contribute to infection
control. A more likely scenario in vivo is that high local
concentrations of Hla at the site of infection, in combination with
other potentially cytolytic factors, would lead to the necrotic death
of tissue eosinophils, with consequent release of injurious granule
contents causing damage to the surrounding cells and perpetuating
inflammation [58]. This unfavourable host situation may be of some
benefit to the pathogen in that local immune responses may be
hindered by the necrotic debris and loss of tissue architecture would
favour further colonisation and allow dissemination of infection. We
also speculate that lysis of tissue eosinophils by Hla would lead to the
liberation of pre-formed pools of the eosinophil chemoattractants
IL-6 and RANTES, therefore recruiting further eosinophils to the
area [59]. These phenomena could potentially explain the tissue
eosinophilia observed in S. aureus disease.
These data are the first example of a pro-necrotic effect of Hla
on human eosinophils, and may in part explain tissue inflamma-
tion seen in S. aureus colonisation of allergic disease.
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